An optimal non-viral gene transfer method for genetically modifying porcine bone marrow-derived endothelial progenitor cells for experimental therapeutics

No currently available treatment is able to generate new contractile tissue or significantly improve cardiac function after myocardial infarction (MI), a leading cause of morbidity and mortality worldwide. Although gene transfer-enhanced endothelial progenitor cells (GTE-EPCs) show effectiveness in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qiuwang, Wang, Chenxi, Cheema, Zayed M, Kutryk, Michael JB
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358567/
https://www.ncbi.nlm.nih.gov/pubmed/34283683
http://dx.doi.org/10.1177/00368504211024113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358567/
https://www.ncbi.nlm.nih.gov/pubmed/34283683
http://dx.doi.org/10.1177/00368504211024113

Ejemplares similares